Fig 3. in vivo cellular source of HIV from viremic participants.

(A) CD26/input ratio in participant matched CSF and plasma from viremic participants where both were detectable (n = 32). (B) CD26/input ratio for all available samples (n = 34 for CSF, n = 48 plasma) from CSF and plasma of viremic study participants compared to virus derived from in vitro infected MDM and T cells. p-values are * < 0.05; ** < 0.01 as determined by the Kruskal-Wallis test with Dunn multiple comparison correction.